Kuziva Chirwere Chetachiona cheHIV

Hazvishamisi kuti vanhu vauye kuhofisi yechiremba avo vane zviratidzo zvisingaiti zvakadai sefivha, misoro, misumbu / majoka aches uye maronda. muzviitiko zvakawanda, zvinenge zvichinyatsozivikanwa sechirwere, mushure mokunge murwere aizotumirwa kumba achishungurudzika uye anorayira kuzorora uye kunwa mvura zhinji.

Asi zvii zviratidzo izvi zvinoratidza chimwe chinhu?

Ko isu (uye vanachiremba vedu) tinogona kunge tisinganyatsonzwisisi zvinyorwa nekusvetuka kune vekutanga, zvisinei nekufungisisa, kuongororwa here?

Nhasi, tinofanira kugara tichifunga nezvehutachiona hweHIV kune avo vari pangozi yekutapukirwa, kusanganisira varume vanoita zvepabonde nevarume (MSM) uye vechidiki vanoita zvepabonde uye vechidiki .

Kunyange zvazvo zviratidzo zvakanyorwa pamusoro apa zvisingashandisi zviratidzo zvinonzwisisika, zviratidzo zvinowanzoonekwa kune avo vane hutachiwana hutachiwana hwehutachiona hwehutachiwana hweHIV (chirwere chinonzi HIV syndrome, acute retroviral syndrome kana seroconversion yakaoma).

Chii Chinonzi HIV Syndrome?

Acute HIV syndrome inopinda mumuviri kune hutachiwana hutachiona hweHIV, hunova nechiratidzo chakafanana nechochirwere kana mononucleosis. Iko kunowanikwa munzvimbo ipi zvayo kubva pa30-50% yevanhu vatsva vanotapukirwa, vane zviratidzo kubva kubva kune zvishoma kusvika kune yakaoma.

Zviratidzo zvinokonzerwa nekushandiswa kwemuviri kunorwadza kwekudzivirirwa kwezvirwere zvekuzvidzivirira, iyo inonzi pro-inflammatory enzymes uye majiti anobudiswa semasero emusununguko anorwa kurwisa neutralizing vakuvadzwa nevarwere.

Kunyange zvazvo zvinonzwisisika kuti munhu angasuwa zviratidzo izvi kana agere muhofisi yechiremba, pane dzimwe nguva zvinyorwa zvinogona kuratidza kuti ichi chinhu chakakomba. Pakati pavo:

Kunyange pasina chimwe chezviitiko izvi chiri mukati uye pachavo zviratidzo zvakananga zvekutapukirwa kweHIV, vanonyatsotenderana kutsvakurudza nekuongorora

Sei Kuziva Kurwara KweHIV Kwakakosha?

Chokutanga uye chinonyanya kukosha, kuongororwa kwekare kweHIV kunopa munhu anenge achangotapukirwa ane mukana wekurumidza kushandisa antiretroviral therapy (ART) . Kutanga kushandiswa kweART kunobatanidzwa nehutano hushoma hwehutano asi hunowedzera mikana yekuwana pedyo-yakasarudzwa kune hupenyu huripo huri kune avo vanotapukirwa.

Dzimwe tsvakurudzo dzakaratidzawo kuti kupindira kwepakutanga kunogona kuderedza chirwere chekuwedzera kuburikidza nekudzivirira hutachiona kubva pakugadzira matanda akavanzika mumasero uye maviri emuviri. Mukuita kudaro, kurwara kusingaperi kunobatanidza nehutachiona hunogara kwenguva refu kunogona kuderedzwa, kuderedzera njodzi yekusava nehutachiwana hweHIV.

Kuziva

Mutsva inosanganiswa antibody / antigen test s iri nani pakutsvaga kutanga utachiona hweHIV munguva pfupi kana ichienzaniswa nemuedzo weanoriphosi unorasikirwa nehuwandu hwemapfumbamwe makumi matatu ematambudziko.

Kunyange zvazvo kuchiri kukwanisa kwekusaziva, zvimwe zvizvarwa zvitsva zvinowanikwa zvekare zvinokwanisa kusimbisa kupfuura makumi mapfumbamwe makumi matatu ematambudziko matsva eHIV.

Zvinodiwa Kuti Zviitwe

Kunyange zvazvo vazhinji vangaratidza kuti iro basa rechiremba kuti riongorore, zvakakosha kuti varwere vabatane nekuzvipira, zvizere uye zvakatendeseka, chero tsika ipi zvingave yakavaisa pangozi ye HIV. Zvakanyatsojeka kukumbira kuongororwa kweHIV, iyo US Preventive Services Task Force inokurudzira kuti vose veAmerica vave nemakore 15-65 sechikamu chekushanya kwechiremba nguva dzose.

Vanachiremba uye vashandi vekliniki vanofanirwawo kuongororwa nemirairo iyi uye vanoita tsika yekuratidza kuongororwa kweHIV kwevarwere vavo, zvikurukuru munharaunda dzine huwandu hwakawanda hweHIV.

Sources:

Iyo INSIGHT START Chidzidzo Chekudzidza. "Kutanga kweAntiretroviral Therapy muAt Early Asymptomatic HIV Infection." New England Journal of Medicine. July 20, 2015; DOI: 10.1056 / NEJMoa1506816.

Moyer, V. "Kuongorora kweHIV: US Preventive Services Task Force Recommendation Statement." . Anals of Internal Medicine. April 30, 2013; doi: 10.7326 / 0003-4819-159-1-201307020-00645.